Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment

A sustained increase in type I interferon (IFN-I) may accompany clinical manifestations and disease activity in systemic autoimmune diseases (SADs). Despite the very frequent presence of IFN-I in SADs, clinical manifestations are extremely varied between and within SADs. The present short review wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Chasset, François, Dayer, Jean-Michel, Chizzolini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112244/
https://www.ncbi.nlm.nih.gov/pubmed/33986670
http://dx.doi.org/10.3389/fphar.2021.633821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112244/
https://www.ncbi.nlm.nih.gov/pubmed/33986670
http://dx.doi.org/10.3389/fphar.2021.633821

Ejemplares similares